Showing results (71-80 of 238) with videos related to
Sort By:
Pageof 24
Blood|June 16, 2012
How I treat hematologic emergencies in adults with acute leukemiaTsila Zuckerman, Chezi Ganzel, Martin S Tallman, et al.Blood|January 25, 2002
Acute promyelocytic leukemia: evolving therapeutic strategiesMartin S Tallman, Chadi Nabhan, James H Feusner, et al.Cancer Immunology, Immunotherapy : CII|January 18, 2012
Rituximab-induced direct inhibition of T-cell activationDina Stroopinsky, Tamar Katz, Jacob M Rowe, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 23, 2023
What Influences the Decision to Proceed to Transplant for Patients With AML in First Remission?Susan DeWolf, Martin S Tallman, Jacob M Rowe, et al.European Journal of Immunology|July 28, 2009
Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacityDina Stroopinsky, Irit Avivi, Jacob M Rowe, et al.Current Drug Safety|August 12, 2008
Busulfan use in hematopoietic stem cell transplantation: pharmacology, dose adjustment, safety and efficacy in adults and childrenNorberto Krivoy, Erica Hoffer, Yael Lurie, et al.Seminars in Hematology|September 6, 2002
Future clinical implications for farnesyltransferase inhibitors in hematologic malignanciesHagop M Kantarjian, Jorge E Cortes, Jacob M Rowe, et al.Blood Reviews|September 6, 2021
Consolidation in AML: Abundant opinion and much unknownNir Weigert, Jacob M Rowe, Hillard M Lazarus, et al.Plos One|October 3, 2012
Patterns of information-seeking for cancer on the internet: an analysis of real world dataYishai Ofran, Ora Paltiel, Dan Pelleg, et al.Leukemia Research|June 2, 2019
Efficacy outcomes in the treatment of older or medically unfit patients with acute myeloid leukaemia: A systematic review and meta-analysisA Stone, Tsila Zukerman, Liat Flaishon, et al.Pageof 24